Joinn Laboratories(China)Co.,Ltd. (SHA:603127)

Market Cap	27.14B +130.3%
Revenue (ttm)	1.69B -14.9%
Net Income	495.08M +27.8%
EPS	0.68 +33.4%
Shares Out	733.37M
PE Ratio	58.78
Forward PE	74.95
Dividend	0.12 (0.31%)
Ex-Dividend Date	Aug 14, 2025

Volume	40,503,050
Average Volume	34,721,339
Open	39.90
Previous Close	40.13
Day's Range	38.70 - 41.16
52-Week Range	15.67 - 45.95
Beta	0.92
RSI	61.83
Earnings Date	Apr 29, 2026

About SHA:603127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provide clinical contract research organization s...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 2,649
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603127

Financial Performance

In 2025, SHA:603127's revenue was 1.66 billion, a decrease of -17.87% compared to the previous year's 2.02 billion. Earnings were 297.84 million, an increase of 302.08%.